CARLSBAD, Calif., May 11, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) is proud to announce that
"Global Volunteer Day has long been the cornerstone of our efforts to support and strengthen our communities," said Gregory T. Lucier, Chairman and Chief Executive Officer of Life Technologies. "Even as we expand our philanthropic efforts each year, and encourage our employees to dedicate their time year-round to volunteer opportunities, this day of giving as a global team will continue to be one of the company's proudest citizenship achievements."
Last year, Life Technologies launched the 'Giving back at LIFE' initiative, an employee year-round volunteer program aimed at helping facilitate community service participation among Life Technologies' workforce, ultimately volunteering for more than 37,000 hours of community service outside of the company's corporate programs.
On Global Volunteer Day, Life Technologies provides each of its employees with a half day of paid time to participate in volunteer projects. Follow #LIFEGVD on Twitter.com to see real time updates from Life Technologies employees at locations around the world, helping out at service projects including:
This year's Global Volunteer Day also marks the launch of a new hands-on science program the company plans to sponsor and incorporate into educational curricula throughout the U.S. Life Technologies' long-term intention is to broaden this interactive program into schools throughout the world.
For the second year in a row, Life Technologies will host area students for Global Volunteer Day, where area school students from San Diego will participate in real-life biotechnology experiments activity and career discussions with a variety of Life Technologies professionals and will also participate in a resume review and practice job interviews hosted by the company's human resources team.
As San Diego High School science teacher Sara Dozier commented, "My biotechnology class visited Life Technologies last spring and the visit certainly made a lasting impression." "The visit was incredibly important to the students and the individual activities, including resume work shopping, gel electrophoresis, career conversations and the tour, all impacted the students in different ways. The experience inspired the students to strive for more than they ever thought possible for themselves."
"This is our ultimate goal for this new educational initiative – to bring science back into the classroom," added Lucier. To not only educate but to inspire and hopefully instill a spirit of innovation and appreciation for the sciences for the next generation of scientists."
Lastly, the day would not be complete without the inaugural unveiling of the company's mascot – the Giving Gene. Moving forward, Gene will be the face of 'Giving Back at LIFE,' making personal appearances throughout the communities where Life Technologies operates.
Life Technologies' community relations and corporate social responsibility efforts have been recognized by the Dow Jones Sustainability Index, the Investor Relations Global Rankings, and in CRO Magazine's Top 100 corporate citizens.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
ContactPatty Zamora, Corporate Media Relations760email@example.com
SOURCE Life Technologies Corporation
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All